Published in AIDS Res Hum Retroviruses on January 01, 2009
Origin and dynamics of HIV-1 subtype C infection in India. PLoS One (2011) 0.92
Transmitted drug resistance in nonsubtype B HIV-1 infection. HIV Ther (2009) 0.90
Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men. AIDS Res Hum Retroviruses (2013) 0.87
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe. PLoS One (2010) 0.81
Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis. AIDS Res Hum Retroviruses (2014) 0.78
Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Res Notes (2011) 0.76
Major HIV resistance mutations in untreated Romanian patients. J Med Life (2011) 0.76
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis (2013) 2.19
Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions. J Infect Dis (2003) 2.17
Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis (2006) 2.14
Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world. AIDS Rev (2012) 1.95
Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2002) 1.49
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]. Ned Tijdschr Geneeskd (2013) 1.39
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time. PLoS One (2010) 1.33
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J Acquir Immune Defic Syndr (2004) 1.17
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. J Antimicrob Chemother (2011) 1.01
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions. AIDS (2002) 0.96
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. J Infect Dis (2013) 0.94
Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol (2009) 0.94
Use of molecular beacons and multi-allelic real-time PCR for detection of and discrimination between virulent Bacillus anthracis and other Bacillus isolates. J Microbiol Methods (2009) 0.94
Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus. Clin Infect Dis (2008) 0.92
Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS (2004) 0.92
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study. AIDS (2014) 0.91
Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J Clin Virol (2011) 0.91
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
The impact of human allelic variation on HIV-1 disease. Curr HIV Res (2003) 0.90
Implications of HIV-1 M group polymorphisms on integrase inhibitor efficacy and resistance: genetic and structural in silico analyses. Biochemistry (2009) 0.89
Near-full genome characterisation of two natural intergenotypic 2k/1b recombinant hepatitis C virus isolates. Adv Virol (2011) 0.89
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study. PLoS One (2013) 0.88
Short communication: molecular epidemiology of HIV type 1 infection in northern Greece (2009-2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains among men who have sex with men. AIDS Res Hum Retroviruses (2013) 0.87
Molecular beacon-based real-time PCR detection of primary isolates of Salmonella Typhimurium and Salmonella Enteritidis in environmental and clinical samples. BMC Microbiol (2009) 0.87
Near-full genome characterization of unclassified hepatitis C virus strains relating to genotypes 1 and 4. J Med Virol (2011) 0.86
Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance. AIDS Res Hum Retroviruses (2011) 0.86
Cost-effectiveness of PrEP in HIV/AIDS control in Zambia: a stochastic league approach. J Acquir Immune Defic Syndr (2014) 0.85
Viral correlates of HIV-1 disease. Curr HIV Res (2005) 0.84
Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol (2010) 0.84
Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus. PLoS One (2013) 0.84
Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms. J Acquir Immune Defic Syndr (2011) 0.83
Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection. AIDS Res Hum Retroviruses (2009) 0.82
Global genetic variation of HIV-1 infection. Curr HIV Res (2006) 0.82
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe. PLoS One (2010) 0.81
Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance. Bioorg Med Chem (2009) 0.81
Cellular HIV type 1 DNA levels are equivalent among drug-sensitive and drug-resistant strains in newly diagnosed and antiretroviral naive patients. AIDS Res Hum Retroviruses (2013) 0.80
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. BMC Infect Dis (2013) 0.78
HIV-1 integrase: from biology to chemotherapeutics. Curr HIV Res (2007) 0.77
Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2004) 0.77
Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts. BMC Res Notes (2011) 0.76